Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis

Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Manuel L. Fernández Guerrero(Hospital Universitario Fundación Jiménez Díaz), Pablo Avilés(PharmaMar (Spain)), Carlos Gimeno Verdejo(Hospital Universitario Fundación Jiménez Díaz)
Antimicrobial Agents and Chemotherapy
April 1, 1995
10.1128/aac.39.4.953
Cited by 49

Related Papers

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
|Science|2021|364
Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain
|PLoS ONE|2018|179
Severe Dengue Virus Infection in Travelers: Risk Factors and Laboratory Indicators
|The Journal of Infectious Diseases|2007|173
Hospital-Acquired Infectious Endocarditis Not Associated with Cardiac Surgery: An Emerging Problem
|Clinical Infectious Diseases|1995|170
The Spectrum of Cardiovascular Infections due to Salmonella enterica
|Medicine|2004|155